Drreddys Laboratories | RDY - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
ANI Pharmaceuticals USD 3.64M 775K 2026-06
Aurora Cannabis CAD 230K 1.88M 2026-03
Bayer EUR 675M 87M 2025-12
Canopy Growth CAD 12.31M 4.97M 2026-03
Cipla INR 170.3M 39M 2026-06
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Drreddys Laboratories INR 1.06B 113M 2026-03
GlaxoSmithKline GBP 121M 46M 2026-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Lonza CHF 84M 14M 2025-06
Novartis USD 462M 119M 2026-06
Pacira USD 3.62M 77K 2026-06
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 13.94M 2.52M 2026-06
Richter Gedeon HUF 7.5B 9.53B 2024-09
Sun Pharmaceuticals INR 859M 139.6M 2026-03
Supernus Pharmaceuticals USD 910K 278K 2023-06
Teva Pharmaceutical Industries USD 195M 21M 2026-06